Literature DB >> 27472410

Novel B-cell subsets in atherosclerosis.

Hidde Douna1, Johan Kuiper.   

Abstract

PURPOSE OF REVIEW: The number of deaths associated with cardiovascular disease remains high, despite great advances in treating the associated high levels of cholesterol. The main underlying pathology of cardiovascular disease is atherosclerosis, which is recognized as a chronic autoimmune-like inflammatory disease. Hence, there is a pressing need to shed light on the immune pathways associated with atherosclerosis. B cells have long been thought to have a general protective effect in atherosclerosis. However, findings in the last decade have challenged this paradigm, showing that it is crucial to differentiate between the various B-cell subsets when assessing their role/effect on atherosclerosis. RECENT
FINDINGS: It has become increasingly recognized lately that B cells can have significant effects on the immune system independent of antibody production. The understanding that B cells form a major source of cytokines and can directly influence T-cell responses via surface markers, have led to the identification of novel B-cell subsets. These subsets are important modulators of autoimmune disorders but have not yet been fully investigated in atherosclerosis.
SUMMARY: Here we review the current known roles of B-cell subsets and the putative effects of recently identified B cells on atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27472410     DOI: 10.1097/MOL.0000000000000335

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  3 in total

Review 1.  The Dynamics of B Cell Aging in Health and Disease.

Authors:  Jill de Mol; Johan Kuiper; Dimitrios Tsiantoulas; Amanda C Foks
Journal:  Front Immunol       Date:  2021-10-05       Impact factor: 7.561

Review 2.  Immunomodulatory Treatment Strategies Targeting B Cells for Heart Failure.

Authors:  Xinxin Zhang; Yuxi Sun; Ning Wang; Yanli Zhang; Yunlong Xia; Ying Liu
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810

Review 3.  Leukocyte Trafficking via Lymphatic Vessels in Atherosclerosis.

Authors:  Kim Pin Yeo; Hwee Ying Lim; Veronique Angeli
Journal:  Cells       Date:  2021-05-29       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.